These new compounds are some of the only new class of antibiotics to join the market recently as human therapeutics

Invitrogen TrueCut Cas9 Protein v2 is a next generation CRISPR-Cas9 protein designed to deliver maximum editing efficiency in a broad range of cells

New cas9 protein and synthetic gRNA strengthen Thermo Fisher Scientific's portfolio of genome editing products

Selective C-H functionalization holds particular promise for the pharmaceutical industry

The technique is expected to find application not just in the pharmaceutical chemistry industry but also in a wide range of other chemical industries

A diabetes drug currently undergoing development could be repurposed to help end transplant rejection, without the side-effects of current immunosuppressive drugs

Technique may predict which therapies a patient is most sensitive or resistant to

Drugs designed to halt cancer growth may offer a new way to control high blood pressure

Berkeley scientists use cryo-EM to capture alarm-sounding protein ring

The advanced breath simulators, the BRS 2100 and BRS 3100, are designed for orally inhaled product (OIP) development and testing